Zhongzhi Pharmaceutical Holdings Limited

Zhongzhi Pharmaceutical Holdings Limitedverified

3737.HK

Price:

$0.59

Market Cap:

$450.62M

Zhongzhi Pharmaceutical Holdings Limited, an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People's Republic of China. The company operates through three segments: Pharmaceutical Manufacturing, Operation of Chain Pharmacies, and Operation of On-Line Pharmacies. It provides Chinese patent medicines and decoction pieces under the Zeus, Liumian, and Caojinghua brands. The company is also manufacture and sale of food and Chinese herbs; property management; and pharmaceutical drugs, as well as offers detection and testing services. As of December 31, 2021, it operated 398 self-operated chain pharmacies, including 361 medi...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2015-07-13

Stock Exchange

HKSE

Ticker

3737.HK

The Enterprise Value as of December 2025 (TTM) for Zhongzhi Pharmaceutical Holdings Limited (3737.HK) is 444.60M

According to Zhongzhi Pharmaceutical Holdings Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 444.60M. This represents a change of -52.83% compared to the average of 942.65M of the last 4 quarters.

Zhongzhi Pharmaceutical Holdings Limited (3737.HK) Historical Enterprise Value (quarterly & annually)

How has 3737.HK Enterprise Value performed in the past?

The mean historical Enterprise Value of Zhongzhi Pharmaceutical Holdings Limited over the last ten years is 814.43M. The current 444.60M Enterprise Value has changed 5.36% with respect to the historical average. Over the past ten years (40 quarters), 3737.HK's Enterprise Value was at its highest in in the June 2016 quarter at 1.46B. The Enterprise Value was at its lowest in in the June 2013 quarter at 0.

Quarterly (TTM)
Annual

Average

814.43M

Median

794.23M

Minimum

605.06M

Maximum

1.16B

Zhongzhi Pharmaceutical Holdings Limited (3737.HK) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Zhongzhi Pharmaceutical Holdings Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 92.21%

Maximum Annual Enterprise Value = 1.16B

Minimum Annual Increase = -41.68%

Minimum Annual Enterprise Value = 605.06M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2024807.59M-30.56%
20231.16B92.21%
2022605.06M-1.96%
2021617.16M-41.68%
20201.06B49.59%
2019707.49M-7.59%
2018765.62M-2.38%
2017784.32M-5.69%
2016831.62M3.42%
2015804.14M-27.07%

Zhongzhi Pharmaceutical Holdings Limited (3737.HK) Average Enterprise Value

How has 3737.HK Enterprise Value performed in the past?

The current Enterprise Value of Zhongzhi Pharmaceutical Holdings Limited (3737.HK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

858.55M

5-year avg

850.22M

10-year avg

814.43M

Zhongzhi Pharmaceutical Holdings Limited (3737.HK) Enterprise Value vs. Peers

How is 3737.HK’s Enterprise Value compared to its peers?

Zhongzhi Pharmaceutical Holdings Limited’s Enterprise Value is less than Wai Yuen Tong Medicine Holdings Limited (747.51M), less than China NT Pharma Group Company Limited (800.35M), greater than Modern Chinese Medicine Group Co., Ltd. (68.83M), less than Fusen Pharmaceutical Company Limited (824.05M), greater than MOG Holdings Limited (204.78M), less than Austar Lifesciences Limited (642.56M), less than Vincent Medical Holdings Limited (485.95M), less than Charmacy Pharmaceutical Co., Ltd. (1.23B), greater than Yunkang Group Limited (370.42M), less than Kato (Hong Kong) Holdings Limited (699.79M),

Build a custom stock screener for Zhongzhi Pharmaceutical Holdings Limited (3737.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Zhongzhi Pharmaceutical Holdings Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Zhongzhi Pharmaceutical Holdings Limited (3737.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Zhongzhi Pharmaceutical Holdings Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Zhongzhi Pharmaceutical Holdings Limited's Enterprise Value?

What is the highest Enterprise Value for Zhongzhi Pharmaceutical Holdings Limited (3737.HK)?

What is the 3-year average Enterprise Value for Zhongzhi Pharmaceutical Holdings Limited (3737.HK)?

What is the 5-year average Enterprise Value for Zhongzhi Pharmaceutical Holdings Limited (3737.HK)?

How does the current Enterprise Value for Zhongzhi Pharmaceutical Holdings Limited (3737.HK) compare to its historical average?